Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:43 PM
Ignite Modification Date:
2025-12-24 @ 4:43 PM
NCT ID:
NCT00186966
Eligibility Criteria:
Inclusion Criteria:
* Children and adolescents less than eighteen years of age at start of chemotherapy.
* Subject has one of the following: Primary refractory AML, first relapsed AML, second or subsequent relapsed AML and was not previously treated according to this particular protocol
* Subjects with a combined relapse, or an isolated extramedullary relapse, or a bone marrow relapse are eligible, also for randomization.
Exclusion Criteria:
* Symptomatic cardiac dysfunction.
* Inadequate performance score.
* Any other organ dysfunction that will interfere with the administration of the therapy.
* FAB type M3
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
18 Years
Study:
NCT00186966
Study Brief:
Protocol Section:
NCT00186966